Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma

The retinoblastoma protein (pRb), p16INK4A, D-type cyclins, and their partners cyclin-dependent kinase (CDK) 4 and 6 constitute a G1 regulatory pathway commonly targeted in tumorigenesis. Several malignancies show a reciprocal correlation between genetic alterations of single members of the pRb path...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krämer, Alwin (VerfasserIn) , Schultheis, Beate (VerfasserIn) , Bergmann, J. (VerfasserIn) , Willer, Andreas (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Hehlmann, Rüdiger (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 August 2002
In: Leukemia
Year: 2002, Jahrgang: 16, Heft: 9, Pages: 1844-1851
ISSN:1476-5551
DOI:10.1038/sj.leu.2402609
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2402609
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2402609
Volltext
Verfasserangaben:A. Krämer, B. Schultheis, J. Bergmann, A. Willer, U. Hegenbart, A.D. Ho, H. Goldschmidt and R. Hehlmann

MARC

LEADER 00000caa a2200000 c 4500
001 1782124403
003 DE-627
005 20220820093834.0
007 cr uuu---uuuuu
008 211214s2002 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.leu.2402609  |2 doi 
035 |a (DE-627)1782124403 
035 |a (DE-599)KXP1782124403 
035 |a (OCoLC)1341436070 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
245 1 0 |a Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma  |c A. Krämer, B. Schultheis, J. Bergmann, A. Willer, U. Hegenbart, A.D. Ho, H. Goldschmidt and R. Hehlmann 
246 3 3 |a Alterations of the cyclin D1/pRb/p16 INK4A pathway in multiple myeloma 
264 1 |c 30 August 2002 
300 |b Diagramme 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.12.2021 
500 |a INK4A im Titel ist hochgestellt 
520 |a The retinoblastoma protein (pRb), p16INK4A, D-type cyclins, and their partners cyclin-dependent kinase (CDK) 4 and 6 constitute a G1 regulatory pathway commonly targeted in tumorigenesis. Several malignancies show a reciprocal correlation between genetic alterations of single members of the pRb pathway. Therefore, we determined the frequency of Rb deletions and cyclin D1 alterations by fluorescence in situ hybridization as well as 5′ CpG island hypermethylation of the p16INK4Agene using methylation-specific polymerase chain reaction in bone marrow mononuclear cells from 82 individuals with plasma cell disorders. Alterations in at least one of the components of the pathway were found in 75%. Cyclin D1 translocations or amplifications were detected in 14/82 (17.1%), Rb deletions at 13q14 in 23/82 (28%) of the cases, including three (3.6%) homozygous deletions. p16INK4A was hypermethylated in 33/57 (57.9%) of the samples. Further analysis revealed a highly significant correlation between cyclin D1 alterations and extramedullar or leukemic myeloma manifestations (P = 0.014; Fisher's test). Whereas Rb deletions seemed to occur alternatively to cyclin D1 alterations, no reciprocal correlation was found between p16INK4A hypermethylations and cyclin D1 or Rb locus aberrations. Cyclin D1 locus alterations and Rb deletions were associated with a significantly worse prognosis whereas p16INK4A hypermethylation had no impact on survival. We conclude that cyclin D1 and Rb aberrations seem to occur as alternative events in plasma cell malignancies and contribute to clinical course and prognosis. In contrast, although p16INK4A hypermethylation is frequent, inactivation of p16INK4A seems not to be involved in the pathogenesis of plasma cell disorders. 
650 4 |a Cancer Research 
650 4 |a general 
650 4 |a Hematology 
650 4 |a Intensive / Critical Care Medicine 
650 4 |a Internal Medicine 
650 4 |a Medicine/Public Health 
650 4 |a Oncology 
700 1 |a Schultheis, Beate  |e VerfasserIn  |0 (DE-588)1066228655  |0 (DE-627)817030395  |0 (DE-576)42568038X  |4 aut 
700 1 |a Bergmann, J.  |e VerfasserIn  |4 aut 
700 1 |a Willer, Andreas  |e VerfasserIn  |0 (DE-588)1077762984  |0 (DE-627)837469031  |0 (DE-576)184778565  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 16(2002), 9, Seite 1844-1851  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma 
773 1 8 |g volume:16  |g year:2002  |g number:9  |g pages:1844-1851  |g extent:8  |a Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma 
856 4 0 |u https://doi.org/10.1038/sj.leu.2402609  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/2402609  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211214 
993 |a Article 
994 |a 2002 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |d 61200  |e 60000PH1037003489  |e 61200PH1037003489  |k 0/60000/  |k 1/60000/61200/  |p 8  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |p 5 
998 |g 1077762984  |a Willer, Andreas  |m 1077762984:Willer, Andreas  |d 60000  |d 61200  |e 60000PW1077762984  |e 61200PW1077762984  |k 0/60000/  |k 1/60000/61200/  |p 4 
998 |g 1066228655  |a Schultheis, Beate  |m 1066228655:Schultheis, Beate  |d 60000  |d 61200  |e 60000PS1066228655  |e 61200PS1066228655  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1782124403  |e 4020168490 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1782124403","relHost":[{"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","disp":"Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myelomaLeukemia","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"origin":[{"dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"part":{"volume":"16","extent":"8","year":"2002","pages":"1844-1851","issue":"9","text":"16(2002), 9, Seite 1844-1851"},"language":["eng"]}],"name":{"displayForm":["A. Krämer, B. Schultheis, J. Bergmann, A. Willer, U. Hegenbart, A.D. Ho, H. Goldschmidt and R. Hehlmann"]},"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"id":{"doi":["10.1038/sj.leu.2402609"],"eki":["1782124403"]},"origin":[{"dateIssuedDisp":"30 August 2002","dateIssuedKey":"2002"}],"note":["Gesehen am 14.12.2021","INK4A im Titel ist hochgestellt"],"title":[{"title_sort":"Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma","title":"Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"Alterations of the cyclin D1/pRb/p16 INK4A pathway in multiple myeloma"}],"person":[{"family":"Krämer","display":"Krämer, Alwin","role":"aut","given":"Alwin"},{"family":"Schultheis","display":"Schultheis, Beate","given":"Beate","role":"aut"},{"given":"J.","role":"aut","family":"Bergmann","display":"Bergmann, J."},{"display":"Willer, Andreas","family":"Willer","role":"aut","given":"Andreas"},{"family":"Hegenbart","display":"Hegenbart, Ute","given":"Ute","role":"aut"},{"role":"aut","given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho"},{"role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","given":"Rüdiger","role":"aut"}]} 
SRT |a KRAEMERALWALTERATION3020